Spiro-naphthyridine Antagonists of the Melanocortin Receptor 4 for the Treatment of Cachexia Associated with Chronic Illness

ACS Med Chem Lett. 2022 Jun 9;13(7):997-998. doi: 10.1021/acsmedchemlett.2c00229. eCollection 2022 Jul 14.
No abstract available

Publication types

  • Editorial